 | ||
| SILVERMAN SHIN & BYRNE PLLC | New Jersey | |
| Wall Street Plaza | 19 Engle Street | |
| 22nd Floor | Tenafly, NJ 07670 | |
| 88 Pine Street | (201) 567-4969 | |
| NEW YORK, NY 10005 | ||
| 212.779.8600 | ||
| Facsimile: 212.779.8858 |
February 6, 2019
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549
| Re: | Hemispherx Biopharma, Inc. | |
| Registration Statement on Form S-1 (SEC File No. 333-229051) | ||
| Filed with the Commission on December 27, 2018 |
Dear Sir or Madam:
On behalf of Hemispherx Biopharma, Inc. (the “Company”), we file herewith Amendment No. 1 to the above referenced registration statement. It contains all of the material terms of the rights offering.
As the Company’s financial statements go stale end of day on February 14, 2019, we anticipate requesting acceleration to that date.
If you have any questions, please contact me as soon as possible.
| Very truly yours, | |
| /s/ Richard Feiner | |
| Richard Feiner |
cc: Hemispherx Biopharma, Inc.